• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2013 Fiscal Year Final Research Report

The NO conjugated-albumin nanoparticles for the application to multidisciplinary cancer treatment

Research Project

  • PDF
Project/Area Number 23390142
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Applied pharmacology
Research InstitutionKumamoto University

Principal Investigator

MARUYAMA Toru  熊本大学, 薬学部, 教授 (90423657)

Co-Investigator(Kenkyū-buntansha) ISHIMA Yu  熊本大学, 薬学部, 助教 (00457590)
WATANABE Hiroshi  熊本大学, 薬学部, 准教授 (70398220)
OTAGIRI Masaki  崇城大学, 薬学部, 教授 (80120145)
Project Period (FY) 2011-04-01 – 2014-03-31
KeywordsDDS / アルブミン / 一酸化窒素 / 癌治療
Research Abstract

The enhanced permeability and retention (EPR) effect is a unique phenomenon of solid tumors related to their anatomical and pathophysiological differences from normal tissues, served as a basis for development of macromolecular anticancer therapy. Although many factors that affect vascular permeability in tumors have been identified, some parts of tumors do not exhibit the EPR effect and show less accumulation of macromolecules than other parts. We previously developed S-nitrosated HSA-Dimer (SNO-HSA-Dimer) as an enhancer of the EPR effect by applying nitric oxide (NO)-releasing agents in tumors selectively. In this study, we performed the effect of SNO-HSA-Dimer on the anti-tumor effect of two macromolecular anti-tumor drugs in C26 tumor-bearing mice. Intriguingly, SNO-HSA-Dimer inhibited the side effects of Doxil; through augmenting the EPR effect.

  • Research Products

    (29 results)

All 2014 2013 2012 2011 Other

All Journal Article (8 results) (of which Peer Reviewed: 8 results) Presentation (20 results) Remarks (1 results)

  • [Journal Article] Tuning of Poly-S-Nitrosated Human Serum Albumin as Superior Antitumor Nanomedicine2014

    • Author(s)
      Ishima Y, Fang J, Kragh-Hansen U, Yin H, Liao L, Katayama N, Watanabe H, Kai T, Suenaga A, Maeda H, Otagiri M, Maruyama T
    • Journal Title

      J Pharm Sci

    • DOI

      10.1002/jps.24020

    • Peer Reviewed
  • [Journal Article] Albumin Fusion Prolongs the Antioxidant and Anti-Inflammatory Activities of Thioredoxin in Mice with Acetaminophen-Induced Hepatitis2014

    • Author(s)
      Tanaka R, Ishima Y, Maeda H, Kodama A, Nagao S, Watanabe H, Chuang VT, Otagiri M, Maruyama T
    • Journal Title

      Mol Pharm

    • DOI

      10.1021/mp400690v

    • Peer Reviewed
  • [Journal Article] Poly-s-nitrosated albumin as a safe and effective multifunctional antitumor agent : characterization, biochemistry and possible future therapeutic applications2013

    • Author(s)
      Ishima Y, Kragh-Hansen U, Maruyama T, Otagiri M
    • Journal Title

      Biomed Res Int

      Volume: 2013 Pages: 353892

    • DOI

      10.1155/2013/353892

    • Peer Reviewed
  • [Journal Article] UW solution improved with high anti-apoptotic activity by S-nitrosated human serum albumin2013

    • Author(s)
      Ishima Y, Shinagawa T, Yoneshige S, Kragh-Hansen U, Ohya Y, Inomata Y, Kai T, Otagiri M, Maruyama T
    • Journal Title

      Nitric Oxide

      Pages: 36-42

    • DOI

      10.1016/j.niox.2013.01.004

    • Peer Reviewed
  • [Journal Article] Elucidation of the therapeutic enhancer mechanism of poly-S-nitrosated human serum albumin against multidrug-resistant tumor in animal models2012

    • Author(s)
      Ishima Y, Hara M, Kragh-Hansen U, Inoue A, Suenaga A, Kai T, Watanabe H, Otagiri M, Maruyama T
    • Journal Title

      J Control Release

      Volume: 164(1) Pages: 1-7

    • DOI

      10.1016/j.jconrel.2012.10.003

    • Peer Reviewed
  • [Journal Article] S-guanylation of human serum albumin is a unique posttranslational modification and results in a novel class of antibacterial agents2012

    • Author(s)
      Ishima Y, Hoshino H, Shinagawa T, Watanabe K, Akaike T, Sawa T, Kragh-Hansen U, Kai T, Watanabe H, Maruyama T, Otagiri M
    • Journal Title

      J Pharm Sci

      Volume: 101(9) Pages: 3222-9

    • DOI

      10.1002/jps.23143

    • Peer Reviewed
  • [Journal Article] S-Nitrosated human serum albumin dimer is not only a novel anti-tumor drug but also a potentiator for anti-tumor drugs with augmented EPR effects2012

    • Author(s)
      Ishima Y, Chen D, Fang J, Maeda H, Minomo A, Kragh-Hansen U, Kai T, Maruyama T, Otagiri M
    • Journal Title

      Bioconjug Chem

      Volume: 23(2) Pages: 264-71

    • DOI

      10.1021/bc2005363

    • Peer Reviewed
  • [Journal Article] Cellular uptake mechanisms and responses to NO transferred from mono- and poly-S-nitrosated human serum albumin2011

    • Author(s)
      Ishima Y, Yoshida F, Kragh-Hansen U, Watanabe K, Katayama N, Nakajou K, Akaike T, Kai T, Maruyama T, Otagiri M
    • Journal Title

      Free Radic Res

      Volume: 45(10) Pages: 1196-206

    • DOI

      10.3109/10715762.2011.606814

    • Peer Reviewed
  • [Presentation] アルブミンーチオレドキシン誘導体による薬剤性急性腎障害の発症予防と機序解明2013

    • Author(s)
      小玉あずさ, 渡邊博志, 田中遼大, 田中寿絵, 異島優, 深川雅史, 小田切優樹, 丸山徹
    • Organizer
      第35回生体膜と薬物の相互作用シンポジウム
    • Place of Presentation
      東京大学本郷キャンパス
    • Year and Date
      20131121-22
  • [Presentation] 遺伝子組換え型糖鎖付加アルブミンによるクッパー細胞選択的チオール送達は急性肝障害を改善する2013

    • Author(s)
      前田仁志, 平田憲史郎, 渡邊博志, 異島優, 末永綾香, 小田切優樹, 丸山 徹
    • Organizer
      第35回生体膜と薬物の相互作用シンポジウム
    • Place of Presentation
      東京大学本郷キャンパス
    • Year and Date
      20131121-22
  • [Presentation] Therapeutic impact of human serum albumin-thioredoxin fusion protein, long-acting anti-oxidative and anti-inflammatory modulator, against acetaminophen-induced acute liver failure2013

    • Author(s)
      Ryota Tanaka, Hitoshi Maeda, Azusa Kodama, Hiroshi Watanabe, Yu Ishima, Toru Maruyama and Masaki Otagiri
    • Organizer
      Asian Federation for Pharmaceutical Sciences 2013
    • Place of Presentation
      Ramada Plaza Jeju Hotel
    • Year and Date
      20131121-22
  • [Presentation] A human serum albumin-thioredoxin fusion protein prevents experimental contrast-induced nephropathy2013

    • Author(s)
      Hiroshi Watanabe, Azusa Kodama, Ryota Tanaka, Hisae Tanaka, Victor Tuan Giam Chuang, Yu Ishima, Masafumi Fukagawa, Masaki Otagiri, Toru Maruyama
    • Organizer
      Asian Federation for Pharmaceutical Sciences 2013
    • Place of Presentation
      Ramada Plaza Jeju Hotel
    • Year and Date
      20131121-22
  • [Presentation] Poly-S-nitrosated Human Serum Albumin inhibits the Expression of P-glycoprotein Transporter in Human Multidrug-resistant Tumor2013

    • Author(s)
      Yu Ishima, Marie Hara, Hiroshi Watanabe, Masaki Otagiri, Toru Maruyama
    • Organizer
      The 5th Asian Arden conference
    • Place of Presentation
      Aichi Gakuin University
    • Year and Date
      20130806-07
  • [Presentation] A human serum albumin-thioredoxin fusion protein prevents experimental contrast-induced nephropathy2013

    • Author(s)
      Azusa Kodama, Hiroshi Watanabe, Ryota Tanaka, Hisae Tanaka, Victor Tuan Giam Chuang, Yohei Miyamoto, Yu Ishima, Masafumi Fukagawa, Masaki Otagiri, Toru Maruyama
    • Organizer
      The 5th Asian Arden conference
    • Place of Presentation
      Aichi Gakuin University
    • Year and Date
      20130806-07
  • [Presentation] Long-acting human serum albumin-thioredoxin fusion protein suppresses bleomycin-induced pulmonary fibrosis progression2013

    • Author(s)
      Ryota Tanaka, Hiroshi Watanabe, Yu Ishima, Masaki Otagiri, Toru Maruyama
    • Organizer
      The 5th Asian Arden conference
    • Place of Presentation
      Aichi Gakuin University
    • Year and Date
      20130806-07
  • [Presentation] Kupffer cell selective delivery of thiols by genetically engineered mannosylated-albumin as a new therapeutic strategy for hepatitis2013

    • Author(s)
      Hitoshi Maeda, Hiroshi Watanabe, Yu Ishima, Masaki Otagiri, Toru Maruyama
    • Organizer
      The 5th Asian Arden conference
    • Place of Presentation
      Aichi Gakuin University
    • Year and Date
      20130806-07
  • [Presentation] 高分子抗癌剤の腫瘍集積性を高めるS-ニトロソ化アルブミンダイマーのEPR効果増強作用2013

    • Author(s)
      異島優, 方軍, 前田浩, 渡邊博志, 小田切優樹, 丸山徹
    • Organizer
      第13回日本NO学会学術集会
    • Place of Presentation
      沖縄県医師会館
    • Year and Date
      20130628-29
  • [Presentation] 尿毒症物質インドキシル硫酸の生物活性に及ぼす活性酸化窒素種の影響2013

    • Author(s)
      成底 徹, 異島優, 小谷俊介, 中島誠, 渡邊博志, 小田切優樹, 丸山徹
    • Organizer
      第13回日本NO学会学術集会
    • Place of Presentation
      沖縄県医師会館
    • Year and Date
      20130628-29
  • [Presentation] クッパー細胞選択的チオール送達によるアセトアミノフェン肝障害治療法の開発2013

    • Author(s)
      前田仁志, 平田憲史郎 , 渡邊博志, 異島優, 末永綾香, 小田切優樹, 丸山徹
    • Organizer
      日本薬剤学会第28年会
    • Place of Presentation
      愛知, ウインクあいち
    • Year and Date
      20130523-25
  • [Presentation] アルブミン-チオレドキシン融合体によるシスプラチン腎症予防効果2013

    • Author(s)
      小玉あずさ, 田中遼大, 渡邊博志, 異島優, 深川雅史, 小田切優樹, 丸 徹日
    • Organizer
      本薬剤学会第28年会
    • Place of Presentation
      愛知, ウインクあいち
    • Year and Date
      20130523-25
  • [Presentation] 高分子抗癌剤の腫瘍集積性を高めるS-ニトロソ化アルブミンダイマーのEPR効果増強作用2013

    • Author(s)
      異島優, 方軍, 前田浩, 渡邊博志, 小田切優樹, 丸山徹
    • Organizer
      日本薬剤学会第28年会
    • Place of Presentation
      愛知, ウインクあいち
    • Year and Date
      20130523-25
  • [Presentation] アルブミン-チオレドキシン融合蛋白質はヨード造影剤腎症の発症を予防する2013

    • Author(s)
      渡邊博志, 小玉あずさ, 田中遼大, 田中寿絵, 異島優, 深川雅史, 小田切優樹, 丸山徹
    • Organizer
      日本薬剤学会第28年会
    • Place of Presentation
      愛知, ウインクあいち
    • Year and Date
      20130523-25
  • [Presentation] 骨髄標的化エリスロポエチンの製剤設計と腎性貧血治療への応用2013

    • Author(s)
      丸山徹, 宮崎裕理, 田口和明, 渡邊博志, 宗 慶太郎, 田中元子, 松下和孝, 深川雅史, 小田切優樹
    • Organizer
      日本薬剤学会第28年会
    • Place of Presentation
      愛知, ウインクあいち
    • Year and Date
      20130523-25
  • [Presentation] S-ニトロソ化アルブミンにより抗アポトーシス効果を付与した改良型臓器保存液の開発2012

    • Author(s)
      異島優, 品川拓也, 米重梓二, 甲斐俊哉, 赤池孝章, 小田切優樹, 丸山徹
    • Organizer
      第12回日本NO 学会学術集会
    • Place of Presentation
      神戸国際会議場
    • Year and Date
      20120629-30
  • [Presentation] S-ニトロソ化アルブミンダイマーはEPR 効果を増強する2012

    • Author(s)
      井上亜希, 異島優, 方軍, 前田浩, 小田切優樹, 渡邊博志, 丸山徹
    • Organizer
      日本薬剤学会第27年会
    • Place of Presentation
      神戸国際会議場
    • Year and Date
      20120524-26
  • [Presentation] Poly-SNO-アルブミンによる抗癌剤耐性克服効果と機序解明2012

    • Author(s)
      異島優, 原茉梨絵, 末永綾香, 甲斐俊哉, 渡邊博志, 小田切優樹, 丸山徹
    • Organizer
      日本薬学会第132年会
    • Place of Presentation
      北海道大学
    • Year and Date
      2012-03-28
  • [Presentation] 臓器移植保存液としてのS-ニトロソ化アルブミンの有用性評価2011

    • Author(s)
      品川拓也, 異島優, 米重梓二, 末永綾香, 渡邊博志, 丸山徹, 小田切優樹
    • Organizer
      第18回日本血液代替物学会年次大会
    • Place of Presentation
      北海道大学
    • Year and Date
      20111027-28
  • [Presentation] Mono-SNO-HSA とPoly-SNO-HSA による細胞内NO 輸送機構の解明2011

    • Author(s)
      異島優, 原茉梨絵, 末永綾香, 甲斐俊哉, 丸山徹, 小田切優樹
    • Organizer
      第11回日本NO 学会学術集会
    • Place of Presentation
      昭和薬科大学
    • Year and Date
      20110513-14
  • [Remarks]

    • URL

      http://www.pharm.kumamoto-u.ac.jp/Labs/Yakuzai/

URL: 

Published: 2015-06-25  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi